ולטרקס טבליות 500 מג

Country: Ísrael

Tungumál: hebreska

Heimild: Ministry of Health

Virkt innihaldsefni:

VALACICLOVIR AS HYDROCHLORIDE

Fáanlegur frá:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC númer:

J05AB11

Lyfjaform:

טבליות מצופות פילם

Samsetning:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Stjórnsýsluleið:

פומי

Gerð lyfseðils:

מרשם נדרש

Framleitt af:

GLAXO WELLCOME SA, SPAIN

Meðferðarhópur:

VALACICLOVIR

Lækningarsvæði:

VALACICLOVIR

Ábendingar:

Valtrex is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults.Valtrex accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established. Valtrex is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valtrex is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Vörulýsing:

התרופה תינתן למניעת מחלת CMV במושתלי איברים

Leyfisdagur:

2021-02-28

Upplýsingar fylgiseðill

" (
)
-
1986
500
"
500
(
) "
VALACICLOVIR (AS HYDROCHLORIDE)
500
MG
6
.
.
.
,
.
.
.
.
1
.
?
)
HSV
) ,(
VZV
(
-
)
CMV
.(
:
•
.
•
VZV
)
ophthalmic zoster
(
.
•
)
HSV
(
)
(
.
.
•
)
HSV
. (
•
CMV
.
:
.
2
.
:
()
)
6
.(
: ,
•
.
•
.
•
65
.
•
.
-
:
)
DRESS
(
.
DRESS
,
. (
)
← ,
. , . , , .
. / , , , . ,
: .
,
,
, ,
. , , , , ,
.
,
,
,
.
.
)
.(
3
.
?
.
.
.
:
)
zoster
s
Herpe
(
•
1,000
)
"
500
,("
.
•
.
)
sores
Cold
)
(
12
(
•
2,000
) "
500
. ,("
•
12
)
6
. (
•
. (
)
HSV
)
12
(
•
500
. ,"
•
.
3
5
.
HSV
)
12
(
•
500
.
,"
•
.
CMV
)
-
)
(
12
(
•
2,000
) "
500
,("
.
•
6
.
•
.
•
90
,
.
:
•
65
.
•
.
•
.
←
.
.
:
•
.
•
.
•
.//
•
.
•
.
65
.
.
.
.
,
.
,
, , ,
. ,
,
,
,
.
, .
,
. ,
.
. ! .
.
. ,
4
.
,
.
. .
:
←
:
.
.(
)
:
•
,
•
()
, , ,
•
.
) ,
.
DRESS
(
. ,
:
)
COMMON
VERY
(
-
:
•
)
COMMON
(
-
-
10
-
1
100
:
•
•
•
•
•
(
)
•
•
)
UNCOMMON
(
-
-
10
-
1
1,000
:
•
•
()
•
•
•
,
,
,
-
8
.
.
:
•
()
•
•
, ,
(
)
•
( )
•
()
:
•
(
)
•
(
)
•
)
RE
RA
(
-
-
10
-
1
10,000
:
•
()
•
() ,
•
()
•
()
•
()
•
()
,
,
,
-
8
.
.
:
•
)
(
:
•
DRESS
,
,
,
,()
,
.
2
.
•
(tubulointerstitial nephritis) ,
. ,
"
"
)
www.health.gov.il
" ,
(
:
https://sideeffects.health.gov.il/
5
.
?
•
!
.
/
.
•
)
exp. date
(
.
.
•
-
C
30°
.
6
.
• ,
:
Microcrystalline cellulose
Crospovidone
Povidone ,K90
White Colour Concentrate YS-
18043
-
1
(Hypromellose, Titanium dioxide, Polysorbate 80, Polyethylene Glycol
400)
Magnesium stearate
Colloidal Anhydrous Silica
Carnauba wax.
•
:
.
500
"
2
,
10
42
.
-
"
GX CF1
"
.
.
•
:
S.A.
.
, ,
•
:
' ," (
)
25
. ,
•
:
100-39-28426-00
.
,
.
,
.
GSK
.
©
2023
GSK
.
2023
.
Val PT v9A